NCT01072383 - Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

August 31, 2011

Conditions

Psoriasis Vulgaris

Interventions

DRUG

BT061

administration of BT061 either intravenous or subcutaneous

DRUG

placebo treatment

administration of the end formulation buffer of BT061 without active ingredient, either subcutaneous or intravenous

Trial Locations (13)

Dermatologic Clinic, Ostrava

Dermatologic Clinic I, Prague

Dermatologic Clinic Prague III, Prague

Dermatologic Clinic Prague II, Prague

Dermatologic Clinic, Ústí nad Labem

Dermatologic Clinic, Budapest

Dermatologic Clinic, Debrecen

Dermatologic Clinic, Miskolc

Dermatologic Clinic, Szeged

Dermatologic Clinic, Szikszó

Dermatologic Clinic, Szolnok

Dermatologic Clinic, Szombathely

Dermatologic Clinic, Veszprém